Expanded Access

Rocket Pharmaceuticals, Inc. is committed to advancing an integrated and sustainable pipeline of genetic therapies that correct the root cause of complex and rare disorders. After careful and deliberate review of the considerations governing expanded access, we have made the determination that our clinical trials are the most appropriate way to access our investigational gene therapy products at present. For this reason, we do not currently offer an expanded access program (EAP). As a commitment to patients who might potentially benefit from our investigational products, we will continue to review and re-evaluate this policy and will provide ongoing updates on our website as additional clinical study results become available.

Scroll to Top